Guidelines: 2022 ESC Guidelines on cardio-oncology (European Union)

From Beacon
Revision as of 21:19, 1 December 2025 by Lucas (talk | contribs) (Update categories.)

Go back to European Union page

Primary purpose: To assist healthcare professionals in managing cardiovascular health in oncology patients by providing guidance on the prevention, diagnosis, treatment, and monitoring of cancer therapy-related cardiovascular toxicity.

Sponsor, manager or home institution: European Society of Cardiology (ESC).

Type of information: Recommendations about screening, diagnosis, medical procedures, cancer survival information, comorbidities, risk of cancer, primary tumour localization. Click here to learn more.

Cancer Areas of Interest: C00-D48: All neoplasms. Click here to learn more.

Access to information: Click here to access. dataOwner::European Society of Cardiology (ESC) availableVariable::screening availableVariable::diagnosis availableVariable::medical procedures availableVariable::cancer survival availableVariable::comorbidities availableVariable::risk of cancer availableVariable::primary tumour localization hasCancerType::C00-D48: All neoplasms